Neervannan Seshadri sold TARS
September 4, 2026 · Form 4 insider transaction
Neervannan Seshadri sold 4,564 shares of Tarsus Pharmaceuticals, Inc. at $85.00 per share, a transaction worth $387.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,564
Price
$85.00
Total value
$387.9K
InsiderNeervannan Seshadri
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2026
Filing dateSeptember 9, 2026
Shares owned after78,532
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.; Includes 305 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.